GRAIL vs. Mito Health: MCED Cancer Screening Compared
How GRAIL and Mito Health compare for multi-cancer early detection: the Galleri test, a personalized MCED option, ordering, results integration, and support.
Medically reviewed by Rhonda Collins, FNP-C | Mito Health on August 27, 2026.
Quick Summary
GRAIL is the company behind Galleri, a multi-cancer early detection (MCED) blood test that looks for a single shared cancer signal across many cancer types from one draw and predicts the likely signal origin. You order it through a healthcare provider, and it is a strong choice when you want the widest possible net in a single test.
Mito Health is not a competitor to Galleri. Mito offers Galleri too. The difference is choice and context. Through Mito you can order Galleri, or a personalized MCED option in LucenceINSIGHT, and either way the result integrates with the rest of your biomarkers instead of sitting in isolation. Mito adds telehealth ordering, at-cost member pricing on standard bloodwork with a $9/month membership, and Mito Concierge plus 1:1 consults for follow-up. Both Galleri and LucenceINSIGHT are screening tests, not diagnoses, and both are meant to add to, not replace, guideline-recommended cancer screening.
What Is GRAIL / Galleri?
GRAIL is a healthcare company whose flagship product is the Galleri test, a multi-cancer early detection blood test. Rather than reading tumor mutations gene by gene, Galleri looks for a single shared cancer signal that can be present across many cancer types, detected from one blood draw, and returns a predicted cancer signal origin to guide follow-up when a signal is found (Source: grail.com). Galleri is prescription-only and ordered through a healthcare provider.
The model is strongest for breadth. Screening one signal type across a wide range of cancers in a single test can reach cancers that have no routine screening path at all. Like every MCED test, Galleri is an adjunct to guideline-recommended screening, not a replacement, and a result that finds no signal does not mean you are cancer-free.
How Mito and GRAIL Compare
What matters | Mito Health | GRAIL |
|---|---|---|
MCED approach offered | Both: Galleri (single shared signal) and LucenceINSIGHT (personalized ctDNA panel) | Galleri: one shared cancer signal across many cancer types |
Personalization | LucenceINSIGHT Core (6 cancers), Me (7 to 9, chosen with your doctor), or 12 | One broad signal, not a selectable panel |
How you order | Telehealth ordering through Mito | Through a healthcare provider |
Results integration | Integrated with the rest of your biomarkers in one place | Standalone MCED result |
Standard bloodwork | At-cost member pricing with $9/month membership | Focused on the Galleri test |
Support | Mito Concierge plus optional 1:1 consultation | Provider-mediated follow-up |
Details reflect publicly available information and Mito’s current offering. Both Galleri and LucenceINSIGHT are prescription-only screening tests. Confirm current specifications and pricing on each product page before ordering.
Where Mito Has the Edge
Mito’s edge is not that it beats Galleri. Mito sells Galleri. The edge is choice, context, and support around whichever MCED test you pick.
- Two MCED approaches, one place. You can order the broad-net Galleri test, or a personalized option in LucenceINSIGHT Core, Me, or 12. If you want a focused or risk-tailored panel, LucenceINSIGHT Me lets you add up to 3 cancers with your doctor from a curated list of 12. If you want the widest net, Galleri is right there too.
- Results that live with the rest of your health. A Mito MCED result integrates with your other biomarkers, so a cancer screen sits alongside your metabolic, cardiovascular, hormone, and organ markers rather than in a silo.
- Telehealth ordering. You order through Mito rather than arranging it separately.
- At-cost member pricing on standard bloodwork. A $9/month membership unlocks at-cost pricing on routine tests, so ongoing monitoring around an MCED screen is affordable.
- Support after the result. Mito Concierge answers follow-up questions, and you can book a 1:1 consultation to talk through what a result means and what to do next.
Not sure which fits? The Cancer Risk Profile quiz helps you think through your personal risk first.
Where GRAIL Has the Edge
GRAIL is a cancer-detection specialist, and Galleri is a mature, widely studied MCED test with a large evidence base behind its single-signal approach (Source: grail.com). If your priority is one broad screen across as many cancer types as possible, from a single draw, ordered through your own provider, Galleri is a well-established choice on its own terms. Because Galleri is available through providers directly, you do not need to change platforms to get it, and some people prefer ordering through an existing clinical relationship.
Who Should Choose Which
Choose Mito if you want a choice between a broad-net and a personalized MCED test, want the result integrated with the rest of your bloodwork, value telehealth ordering, want at-cost member pricing on standard tests, or want Concierge and 1:1 support around the result. Start with LucenceINSIGHT Core for a focused screen, or Galleri for the widest net, both orderable through Mito.
Choose GRAIL directly if you specifically want the Galleri test, prefer to order it through an existing provider relationship, and do not need it bundled with broader bloodwork or a personalized panel option.
Either way, MCED testing is an adjunct to the cancer screening your doctor already recommends, not a replacement, and a result that finds no signal is not a guarantee you are cancer-free.
FAQs
- Does Mito sell the Galleri test? Yes. You can order Galleri through Mito, and the result integrates with the rest of your biomarkers. See pricing on the product page.
- What is the difference between Galleri and LucenceINSIGHT? Galleri looks for a single shared cancer signal across many cancer types. LucenceINSIGHT sequences circulating tumor DNA and cancer-associated viral DNA on a panel you can keep focused (Core), personalize (Me), or broaden (12). Neither is universally better; it depends on whether you want breadth or a tailored panel.
- Is an MCED test a replacement for a mammogram or colonoscopy? No. Both Galleri and LucenceINSIGHT are adjuncts to guideline-recommended screening. Keep your standard screenings on schedule.
- What happens if a signal is found? A positive or cancer-associated result needs confirmatory workup ordered by a doctor. The predicted origin helps direct follow-up, but it is not a diagnosis.
- Do I need a Mito membership to order an MCED test? No. The $9/month membership unlocks at-cost pricing on standard bloodwork. Check each product page for current MCED pricing.
Also Compare
- Galleri vs. LucenceINSIGHT: Two MCED Blood Tests Compared
- What Is a Multi-Cancer Early Detection (MCED) Test?
- Multi-Cancer Blood Test: Cost and How to Get One
Related Reading
- LucenceINSIGHT Core
- LucenceINSIGHT Me
- LucenceINSIGHT 12
- CA 125 Explained: What Your Cancer Antigen Test Results Mean
References
- Source: grail.com
- Source: Lucence Health validation data
- Source: GLOBOCAN 2024 (gco.iarc.fr)
Medical Disclaimer
This comparison is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Multi-cancer early detection tests are prescription-only screening tests, not diagnostic tests, and they do not replace guideline-recommended cancer screening. A result that finds no cancer signal does not mean you are cancer-free, and a positive result requires confirmatory evaluation ordered by a physician. Product features and pricing are based on publicly available information and may change. Verify current offerings and pricing directly on each product page before ordering.
